Related Experiment Video
Updated: Jan 1, 2026
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
10-Gingerol Inhibits Ovarian Cancer Cell Growth by Inducing G2 Arrest
Andrea Rasmussen1, Kaylee Murphy2, David W Hoskin1,2,3
1Department of Pathology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada.
Abstract:
Gingerol homologs found in the rhizomes of ginger plants have the potential to benefit human health, including the prevention and treatment of cancer. This study evaluated the effect of 10-gingerol on ovarian cancer cell (HEY, OVCAR3, and SKOV-3) growth. Cell growth was measured by MTT assays, flow cytometry was used to assess cell proliferation, cytotoxicity and cell cycle progression, and western blotting was used to measure cyclin protein expression. Ovarian cancer cells that were treated with 10-gingerol experienced a time- and dose-dependent decrease in cell number, which was due to a reduction in cell proliferation rather than a cytotoxic effect. Reduced proliferation of 10-gingerol-treated ovarian cancer cells was associated with an increased percentage of cells in G2 phase of the cell cycle and a corresponding reduction in the percentage of cells in G1. Ovarian cancer cells also showed decreased cyclin A, B1, and D3 expression following exposure to 10-gingerol. These findings revealed that 10-gingerol caused a G2 arrest-associated suppression of ovarian cancer cell growth, which may be exploited in the management of ovarian cancer.
Insights
10-gingerol, a compound from ginger, inhibits ovarian cancer cell growth by reducing proliferation and causing cell cycle arrest. This natural compound may offer new strategies for ovarian cancer management.
Area of Science:
- Phytochemistry
- Oncology
- Molecular Biology
Background:
- Ginger (Zingiber officinale) contains gingerol homologs with potential anti-cancer properties.
- Ovarian cancer remains a significant health challenge, necessitating novel therapeutic approaches.
Purpose of the Study:
- To investigate the anti-cancer effects of 10-gingerol on human ovarian cancer cell lines.
- To elucidate the mechanisms by which 10-gingerol affects ovarian cancer cell growth and proliferation.
Main Methods:
- MTT assays were used to measure cell viability and growth.
- Flow cytometry assessed cell proliferation, cytotoxicity, and cell cycle distribution.
- Western blotting analyzed the expression of key cell cycle regulatory proteins (cyclins).
Main Results:
- 10-gingerol demonstrated a time- and dose-dependent reduction in ovarian cancer cell number.
- The observed decrease in cell number was attributed to reduced proliferation, not direct cytotoxicity.
- 10-gingerol induced a G2 phase cell cycle arrest, with decreased G1 phase population.
- Expression of cyclin A, B1, and D3 was reduced in treated ovarian cancer cells.
Conclusions:
- 10-gingerol suppresses ovarian cancer cell growth through G2 cell cycle arrest.
- These findings suggest 10-gingerol's potential as a therapeutic agent in ovarian cancer management.
Related Concept Videos
02:34Inhibition of Cdk Activity
01:30Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
01:23Negative Regulator Molecules